The significance of IL-6 assessment as a possible predictor of NASH and a tool for early intervention to avoid disease development is highlighted by the high prevalence of NAFLD, a disorder that shares many characteristics with the metabolic syndrome [46,47]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.